Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.

Abstract excerpt

Growing evidence over the last few years suggests a central role of type I IFN pathway in the pathogenesis of systemic autoimmune disorders. Data from clinical and genetic studies in patients with systemic lupus erythematosus (SLE) and lupus-prone mouse models, indicates that the type I interferon system may play a pivotal role in the pathogenesis of several lupus and associated clinical features, such as...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Atherosclerosis
• Share to Disease Models, Animal